Related Experiment Video
Updated: Dec 10, 2025

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as A Novel Detection and Quantification Method
Published on: October 7, 2025
Autophagy-mediating microRNAs in cancer chemoresistance
Yuanming Jing1, Wenqing Liang2, Jian Liu3
1Department of Gastrointestinal Surgery, Shaoxing People's Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, 312000, Zhejiang Province, People's Republic of China.
Abstract:
Chemoresistance is a complex phenomenon responsible for failure in response to chemotherapy agents and more than 90% of deaths in cancer patients. MicroRNAs (miRNAs), as a subgroup of non-coding RNAs with lengths between 21 and 25 nucleotides, are involved in various cancer processes like chemoresistance via interacting with their target mRNAs and suppressing their expression. Autophagy is a greatly conserved procedure involving the lysosomal degradation of cytoplasmic contents and organelles to deal with environmental stresses like hypoxia and starvation. Autophagy contributes to response to chemotherapy agents: autophagy can act as a protective mechanism for mediating the resistance in response to chemotherapy or can induce autophagic cell death and mediate the sensitivity to chemotherapy. On the other hand, one of the processes targeted by microRNAs in the regulation of chemoresistance is autophagy. Hence, we studied the literatures on chemoresistance mechanisms, the miRNAs' role in cancer, and the miRNAs' role in chemoresistance by modulating autophagy. Graphical Abstract.
Insights
MicroRNAs (miRNAs) regulate cancer chemoresistance by modulating autophagy. This study reviews how miRNAs impact chemotherapy effectiveness through autophagy pathways, offering insights into overcoming treatment failure.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Chemoresistance causes over 90% of cancer-related deaths, highlighting an urgent need for novel therapeutic strategies.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and play critical roles in cancer development and progression, including chemoresistance.
- Autophagy, a cellular degradation process, has a dual role in chemotherapy response, either promoting resistance or inducing cell death.
Purpose of the Study:
- To review the intricate mechanisms of chemoresistance in cancer.
- To elucidate the multifaceted roles of miRNAs in cancer, particularly in the context of chemoresistance.
- To explore the regulatory interplay between miRNAs and autophagy in modulating cancer cell response to chemotherapy.
Main Methods:
- Comprehensive literature search on chemoresistance mechanisms.
- Analysis of studies investigating the role of miRNAs in cancer.
- Review of research focusing on miRNA-mediated regulation of autophagy in chemoresistance.
Main Results:
- MicroRNAs are key regulators of chemoresistance, influencing multiple signaling pathways.
- Autophagy can either confer resistance or sensitivity to chemotherapy agents, depending on the cellular context.
- MicroRNAs modulate chemoresistance by targeting key components of the autophagy pathway.
Conclusions:
- Understanding the miRNA-autophagy axis is crucial for developing effective strategies against chemoresistant cancers.
- Targeting specific miRNAs or autophagy pathways holds promise for overcoming chemotherapy resistance.
- Further research into this complex regulatory network may lead to improved cancer treatment outcomes.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Treatment Resistant Cancers
Drugs that Stabilize Microtubules
MicroRNAs
MicroRNAs
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

